✦ LIBER ✦
ENMD-2076, an oral inhibitor of angiogenic and proliferation kinases, has activity in recurrent, platinum resistant ovarian cancer
✍ Scribed by Ursula A. Matulonis; Julie Lee; Brian Lasonde; William P. Tew; Afra Yehwalashet; Daniela Matei; Kian Behbakht; Jill Grothusen; Gini Fleming; Nita K. Lee; Jamie Arnott; Mark R. Bray; Graham Fletcher; Richard D. Brokx; Vincent Castonguay; Helen Mackay; Carolyn F. Sidor; Amit M. Oza
- Book ID
- 119233340
- Publisher
- Elsevier Science
- Year
- 2013
- Tongue
- English
- Weight
- 757 KB
- Volume
- 49
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.